The Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 172 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
1 Industry Overview 1
1.1 Basic Information of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 1
1.1.1 Definition of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 1
1.1.2 Classifications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2
1.1.3 Applications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 3
1.1.4 Characteristics of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 5
1.2 Development Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 6
1.3 Enter Barriers Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 8
2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International and China Market Analysis 9
2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry International Market Analysis 9
2.1.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International Market Development History 9
2.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Analysis 9
2.1.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International Main Countries Development Status 10
2.1.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International Market Development Trend 11
2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry China Market Analysis 11
2.2.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) China Market Development History 11
2.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competitive Landscape Analysis 12
2.2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) China Main Regions Development Status 12
2.2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) China Market Development Trend 12
2.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) International and China Market Comparison Analysis 13
3 Environment Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 14
3.1 International Economy Analysis 14
3.2 China Economy Analysis 17
3.3 Policy Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 18
3.4 News Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 21
4 Analysis of Revenue by Classifications 25
4.1 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 25
4.2 Global Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 27
4.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Classifications 29
5 Analysis of Revenue by Regions and Applications 31
5.1 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2010-2015 31
5.2 2010-2015 USA Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 33
5.3 2010-2015 Europe Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 35
5.4 2010-2015 Japan Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 37
5.5 2010-2015 China Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 39
5.6 2010-2015 Asia-Pacific (EX. China & Japan) Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 41
5.7 2010-2015 South America Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 43
6 Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Status 2010-2015 45
6.1 Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 45
6.2 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 47
6.3 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 53
6.4 Gross Margin of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 55
7 Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Key Players 56
7.1 Janssen 56
7.1.1 Company Profile 56
7.1.2 Revenue and Gross Margin 57
7.1.3 Janssen SWOT Analysis 57
7.2 Qiagen 58
7.2.1 Company Profile 58
7.2.2 Revenue and Gross Margin 58
7.2.3 Qiagen SWOT Analysis 59
7.3 Advanced Cell Diagnostics 59
7.3.1 Company Profile 59
7.3.2 Revenue and Gross Margin 60
7.3.3 Advanced Cell Diagnostics SWOT Analysis 61
7.4 ApoCell 61
7.4.1 Company Profile 61
7.4.2 Revenue and Gross Margin 62
7.4.3 ApoCell SWOT Analysis 63
7.5 Biofluidica 63
7.5.1 Company Profile 63
7.5.2 Revenue and Gross Margin 64
7.5.3 Biofluidica SWOT Analysis 65
7.6 Clearbridge Biomedics 66
7.6.1 Company Profile 66
7.6.2 Revenue and Gross Margin 66
7.6.3 Clearbridge Biomedics SWOT Analysis 67
7.7 CytoTrack 68
7.7.1 Company Profile 68
7.7.2 Revenue and Gross Margin 68
7.7.3 CytoTrack SWOT Analysis 69
7.8 Celsee 69
7.8.1 Company Profile 69
7.8.2 Revenue and Gross Margin 70
7.8.3 Celsee SWOT Analysis 71
7.9 Fluxion 72
7.9.1 Company Profile 72
7.9.2 Revenue and Gross Margin 72
7.9.3 Fluxion SWOT Analysis 73
7.10 Gilupi 73
7.10.1 Company Profile 73
7.10.2 Revenue and Gross Margin 74
7.10.3 Gilupi SWOT Analysis 75
7.11 Cynvenio 75
7.11.1 Company Profile 75
7.11.2 Revenue and Gross Margin 76
7.11.3 Cynvenio SWOT Analysis 77
7.12 On-chip 77
7.12.1 Company Profile 77
7.12.2 Revenue and Gross Margin 78
7.12.3 On-chip SWOT Analysis 79
7.13 YZY Bio 79
7.13.1 Company Profile 79
7.13.2 Revenue and Gross Margin 80
7.13.3 YZY Bio SWOT Analysis 81
7.14 BioView 81
7.14.1 Company Profile 81
7.14.2 Revenue and Gross Margin 82
7.14.3 BioView SWOT Analysis 83
7.15 Creatv MicroTech 84
7.15.1 Company Profile 84
7.15.2 Revenue and Gross Margin 84
7.15.3 Creatv MicroTech SWOT Analysis 85
7.16 Fluidigm 86
7.16.1 Company Profile 86
7.16.2 Revenue and Gross Margin 86
7.16.3 Fluidigm SWOT Analysis 87
7.17 Ikonisys 87
7.17.1 Company Profile 87
7.17.2 Revenue and Gross Margin 88
7.17.3 Ikonisys SWOT Analysis 89
7.18 AdnaGen 89
7.18.1 Company Profile 89
7.18.2 Revenue and Gross Margin 90
7.18.3 AdnaGen SWOT Analysis 91
7.19 IVDiagnostics 92
7.19.1 Company Profile 92
7.19.2 Revenue and Gross Margin 93
7.19.3 IVDiagnostics SWOT Analysis 94
7.20 Miltenyi Biotec 94
7.20.1 Company Profile 94
7.20.2 Revenue and Gross Margin 95
7.20.3 Miltenyi Biotec SWOT Analysis 96
7.21 Aviva Biosciences Corporation 97
7.21.1 Company Profile 97
7.21.2 Revenue and Gross Margin 98
7.21.3 Aviva Biosciences Corporation SWOT Analysis 98
7.22 ScreenCell 99
7.22.1 Company Profile 99
7.22.2 Revenue and Gross Margin 100
7.22.3 ScreenCell SWOT Analysis 101
7.23 Silicon Biosystems 101
7.23.1 Company Profile 101
7.23.2 Revenue and Gross Margin 102
7.23.3 Silicon Biosystems SWOT Analysis 103
8 Sales Price and Gross Margin Analysis 104
8.1 Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104
8.2 Gross Margin Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 105
9 Marketing Trader or Distributor Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 106
9.1 Marketing Channels Status of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 106
9.2 How Countries Meet Their Needs 107
9.2.1 USA 107
9.2.2 China 107
9.2.3 Japan 108
9.2.4 Germany 109
10 Development Trend of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2016-2021 110
10.1 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110
10.2 Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110
11 Industry Chain Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 112
11.1 Equipment Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 112
11.2 Major Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 113
11.3 Key Consumers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 114
11.4 Supply Chain Relationship Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 115
12 New Project Investment Feasibility Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116
12.1 New Project SWOT Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116
12.2 New Project Investment Feasibility Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116
13 Conclusion of the Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry 2015 Market Research Report 118
Tables and Figures
Figure Picture of Circulating Tumor Cells (CTCs) 1
Figure Picture of Cancer Stem Cells (CSCs) 2
Table Classifications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2
Table Applications of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 3
Table Global Major Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players 7
Figure Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2015 10
Table Overview of the World Economic Outlook Projections 14
Figure GDP Growth (Annualized semiannual percent change) Advanced Economies, Emerging Market and Developing Economies 15
Figure Global Aggregates: Headline Inflation 16
Figure GDP Growth by Regions 16
Figure China’s GDP (% Increase on a Year Earlier) 17
Figure Price Movement of Four Chinese Mutual Funds 18
Table Policy of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 18
Table Industry News of Circulating Tumor Cells (CTCs) 21
Table Industry News of Cancer Stem Cells (CSCs) 23
Table Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 25
Figure 2010 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 26
Figure 2015 Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 26
Figure Global CellSearch Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 27
Figure Global Oncoquick Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 28
Figure Global ISET Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 28
Figure Global MACS Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Classifications 2010-2015 29
Table USA Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 29
Table Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 29
Table Japan Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 30
Table China Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (Million USD) by Classifications 30
Table Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2010-2015 31
Figure Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2010 32
Figure Global Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Regions 2015 32
Figure 2010-2015 USA Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 33
Table 2010-2015 USA Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 33
Figure 2010 USA Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 34
Figure 2015 USA Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 34
Figure 2010-2015 Europe Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 35
Table 2010-2015 Europe Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 35
Figure 2010 Europe Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 36
Figure 2015 Europe Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 36
Figure 2010-2015 Japan Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 37
Table 2010-2015 Japan Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 37
Figure 2010 Japan Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 38
Figure 2015 Japan Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 38
Figure 2010-2015 China Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 39
Table 2010-2015 China Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 39
Figure 2010 China Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 40
Figure 2015 China Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 40
Figure 2010-2015 Asia-Pacific (EX. China & Japan) Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 41
Table 2010-2015 Asia-Pacific (EX. China & Japan) Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 41
Figure 2010 Asia-Pacific (EX. China & Japan) Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 42
Figure 2015 Asia-Pacific (EX. China & Japan) Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 42
Figure 2010-2015 South America Revenue and Revenue Growth Rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 43
Table 2010-2015 South America Revenue of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 43
Figure 2010 South America Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 44
Figure 2015 South America Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application 44
Table Revenue (Million USD) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 45
Table Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 46
Figure 2010 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 47
Figure 2011 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 48
Figure 2012 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 49
Figure 2013 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 50
Figure 2014 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 51
Figure 2015 Revenue Market Share Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 52
Table Revenue (Million USD) Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 53
Figure 2010 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 53
Figure 2015 Revenue Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 54
Figure Gross Margin of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2010-2015 55
Table Janssen Company Profile List 56
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Janssen 2010-2015 57
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Janssen 2010-2015 57
Table Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 57
Table Qiagen Company Profile List 58
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Qiagen 2010-2015 58
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Qiagen 2010-2015 59
Table Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 59
Table Advanced Cell Diagnostics Company Profile List 59
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Advanced Cell Diagnostics 2010-2015 60
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Advanced Cell Diagnostics 2010-2015 61
Table Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 61
Table ApoCell Company Profile List 61
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of ApoCell 2010-2015 62
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of ApoCell 2010-2015 63
Table ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 63
Table Biofluidica Company Profile List 63
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Biofluidica 2010-2015 64
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Biofluidica 2010-2015 65
Table Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 65
Table Clearbridge Biomedics Company Profile List 66
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Clearbridge Biomedics 2010-2015 66
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Clearbridge Biomedics 2010-2015 67
Table Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 67
Table CytoTrack Company Profile List 68
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of CytoTrack 2010-2015 68
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of CytoTrack 2010-2015 69
Table CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 69
Table Celsee Company Profile List 69
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Celsee 2010-2015 70
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Celsee 2010-2015 71
Table Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 71
Table Fluxion Company Profile List 72
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Fluxion 2010-2015 72
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Fluxion 2010-2015 73
Table Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 73
Table Gilupi Company Profile List 73
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Gilupi 2010-2015 74
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Gilupi 2010-2015 75
Table Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 75
Table Cynvenio Company Profile List 75
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Cynvenio 2010-2015 76
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Cynvenio 2010-2015 77
Table Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 77
Table On-chip Company Profile List 77
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of On-chip 2010-2015 78
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of On-chip 2010-2015 79
Table On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 79
Table YZY Bio Company Profile List 79
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of YZY Bio 2010-2015 80
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of YZY Bio 2010-2015 81
Table YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 81
Table BioView Company Profile List 81
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of BioView 2010-2015 82
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of BioView 2010-2015 83
Table BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 83
Table Creatv MicroTech Company Profile List 84
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Creatv MicroTech 2010-2015 84
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Creatv MicroTech 2010-2015 85
Table Creatv MicroTech Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 85
Table Fluidigm Company Profile List 86
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Fluidigm 2010-2015 86
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Fluidigm 2010-2015 87
Table Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 87
Table Ikonisys Company Profile List 87
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Ikonisys 2010-2015 88
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Ikonisys 2010-2015 89
Table Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 89
Table AdnaGen Company Profile List 89
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of AdnaGen 2010-2015 90
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of AdnaGen 2010-2015 91
Table AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 91
Table IVDiagnostics Company Profile List 92
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of IVDiagnostics 2010-2015 93
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of IVDiagnostics 2010-2015 93
Table IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 94
Table Miltenyi Biotec Company Profile List 94
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Miltenyi Biotec 2010-2015 95
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Miltenyi Biotec 2010-2015 96
Table Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 96
Table Aviva Biosciences Corporation Company Profile List 97
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Aviva Biosciences Corporation 2010-2015 98
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Aviva Biosciences Corporation 2010-2015 98
Table Aviva Biosciences Corporation Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 98
Table ScreenCell Company Profile List 99
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of ScreenCell 2010-2015 100
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of ScreenCell 2010-2015 100
Table ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 101
Table Silicon Biosystems Company Profile List 101
Table Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Cost, Gross (Million USD) Revenue Growth Rate and Gross Margin of Silicon Biosystems 2010-2015 102
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate of Silicon Biosystems 2010-2015 102
Table Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) SWOT Analysis 103
Table Detection and Diagnosis Equipment Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104
Table Detection and Diagnosis Materials Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104
Table Detection and Diagnosis Service Sales Price Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 104
Table Gross Margin Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 105
Figure Marketing Channels Status of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 106
Table Revenue (Million USD) Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110
Table Detection and Diagnosis Equipment Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 110
Table Detection and Diagnosis Materials Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 111
Table Detection and Diagnosis Service Sales Price Overview of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 2016-2021 111
Table Equipment Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 112
Table Major Suppliers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 113
Table Key Consumers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) with Contact Information 114
Figure Supply Chain Relationship Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 115
Table New Project SWOT Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116
Table New Project Investment Feasibility Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) 116
